See more : FineMat Applied Materials Co., Ltd. (6698.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Bio-Works Technologies AB (publ) (BIOWKS.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bio-Works Technologies AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Nareru Group Inc. (9163.T) Income Statement Analysis – Financial Results
- PT Duta Pertiwi Tbk (DUTI.JK) Income Statement Analysis – Financial Results
- CBTX, Inc. (CBTX) Income Statement Analysis – Financial Results
- Thermal Energy International Inc. (TMGEF) Income Statement Analysis – Financial Results
- BBMG Corporation (601992.SS) Income Statement Analysis – Financial Results
Bio-Works Technologies AB (publ) (BIOWKS.ST)
About Bio-Works Technologies AB (publ)
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.90M | 41.32M | 21.91M | 7.23M | 5.57M | 6.56M | 4.95M | 3.68M | 1.54M |
| Cost of Revenue | 17.08M | 12.47M | 3.35M | 3.02M | 203.00K | 425.00K | -270.00K | -2.89M | -2.75M |
| Gross Profit | 26.82M | 28.85M | 18.56M | 4.22M | 5.37M | 6.14M | 5.22M | 6.56M | 4.29M |
| Gross Profit Ratio | 61.10% | 69.81% | 84.71% | 58.28% | 96.36% | 93.52% | 105.46% | 178.46% | 278.02% |
| Research & Development | 0.00 | 0.00 | 232.00K | 253.00K | 419.00K | 5.20M | 566.00K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 28.35M | 19.78M | 21.13M | 13.98M | 11.56M | 10.64M | 7.98M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 84.33M | 74.95M | 28.35M | 19.78M | 21.13M | 13.98M | 11.56M | 10.64M | 7.98M |
| Other Expenses | 0.00 | 75.99M | 1.17M | 30.09M | 26.37M | 30.31M | 17.23M | 12.99M | 8.55M |
| Operating Expenses | 83.17M | 75.99M | 29.52M | 49.87M | 47.50M | 44.28M | 28.80M | 23.63M | 16.53M |
| Cost & Expenses | 100.24M | 88.46M | 32.87M | 52.89M | 47.70M | 44.71M | 28.53M | 20.74M | 13.78M |
| Interest Income | 882.00K | 347.00K | 72.00K | 114.00K | 120.00K | 127.00K | 12.00K | 403.00K | 160.00K |
| Interest Expense | 3.00K | 23.00K | 18.00K | 9.00K | 0.00 | 2.00K | 98.00K | 495.00K | 281.00K |
| Depreciation & Amortization | 611.00K | 475.00K | 475.00K | 447.00K | 1.36M | 1.74M | 2.23M | 1.98M | 666.00K |
| EBITDA | -54.81M | -46.10M | -10.47M | -45.05M | -40.77M | -31.02M | -21.37M | -15.45M | -11.41M |
| EBITDA Ratio | -124.85% | -106.96% | -39.23% | -622.73% | -723.08% | -472.62% | -431.43% | -399.29% | -740.21% |
| Operating Income | -55.42M | -47.14M | -10.96M | -45.65M | -42.13M | -38.14M | -23.58M | -17.07M | -12.24M |
| Operating Income Ratio | -126.25% | -114.09% | -50.01% | -631.10% | -755.91% | -581.17% | -476.87% | -464.10% | -793.77% |
| Total Other Income/Expenses | 683.00K | 1.40M | 1.59M | 635.00K | 15.00K | -4.45M | -76.00K | -66.00K | -121.00K |
| Income Before Tax | -54.73M | -44.70M | -9.37M | -45.02M | -42.11M | -37.96M | -23.66M | -17.16M | -12.36M |
| Income Before Tax Ratio | -124.69% | -108.17% | -42.77% | -622.33% | -755.66% | -578.32% | -478.40% | -466.60% | -801.62% |
| Income Tax Expense | 2.09M | 255.00K | 3.57M | -470.00K | 1.66M | 189.00K | 22.00K | 403.00K | 160.00K |
| Net Income | -56.82M | -44.95M | -12.94M | -44.55M | -42.11M | -37.96M | -23.66M | -17.16M | -12.36M |
| Net Income Ratio | -129.44% | -108.79% | -59.07% | -615.83% | -755.66% | -578.32% | -478.40% | -466.60% | -801.62% |
| EPS | -1.57 | -1.28 | -0.41 | -1.46 | -1.40 | -1.96 | -1.18 | -0.86 | -0.62 |
| EPS Diluted | -1.57 | -1.28 | -0.41 | -1.46 | -1.40 | -1.88 | -1.18 | -0.86 | -0.62 |
| Weighted Avg Shares Out | 36.11M | 35.01M | 31.21M | 30.42M | 30.11M | 19.33M | 20.03M | 20.03M | 20.03M |
| Weighted Avg Shares Out (Dil) | 36.11M | 35.01M | 31.21M | 30.42M | 30.11M | 20.18M | 20.11M | 20.03M | 20.03M |
Source: https://incomestatements.info
Category: Stock Reports